Quantcast
Last updated on April 24, 2014 at 17:35 EDT

Latest NeoGenomics Inc. Stories

2009-06-05 09:11:00

FT. MYERS, Fla., June 5 /PRNewswire-FirstCall/ -- NeoGenomics, Inc. (NASD OTC Bulletin Board: NGNM) today announced that it will present at the Fifth Annual Noble Financial Equity Conference at 9:15 AM EDT on Monday, June 8, 2009 at the Seminole Hard Rock Hotel in Hollywood, FL.Robert Gasparini, the Company's President and Chief Scientific Officer will give a presentation regarding NeoGenomics' market positioning, financial performance, and strategic direction and then answer questions from...

2009-04-23 07:00:00

Revenue and Gross Margin Increases, Company Achieves Profitability FT. MYERS, Fla., April 23 /PRNewswire-FirstCall/ -- NeoGenomics, Inc. (NASD OTC BB: NGNM), a leading provider of cancer-focused genetic testing services, today reported its results for the first quarter ended March 31, 2009. First Quarter 2009 Highlights: Revenue of $6.9 million, an increase of 66% year-over-year from Q1 08 16.8% sequential increase in revenues from Q4 08 55.3% gross margin up from 53.1% in Q4 08 9.8%...

2009-04-21 17:41:00

FT. MYERS, Fla., April 21 /PRNewswire-FirstCall/ -- NeoGenomics, Inc. (NASD OTC BB: NGNM) announced today that it plans to release its first quarter 2009 financial results on Thursday, April 23, 2009. The Company has scheduled a webcast and conference call to discuss their Q1 2009 results on April 23, 2009, at 11:00 AM EST. Interested investors should dial (877) 407-9210 (domestic) and (201) 689-8049 (international) at least five minutes prior to the call. A replay of the conference call...

2009-03-16 08:11:00

Brings Strong Industry and Executive Level Experience to Company FT. MYERS, Fla., March 16 /PRNewswire-FirstCall/ -- NeoGenomics, Inc. (OTC Bulletin Board: NGNM), a leading provider of cancer genetics testing services, announced today that Douglas M. VanOort, 53 years old, has joined the Company's Board of Directors and been appointed Executive Chairman and Interim Chief Executive Officer. The Company also reported that Mr. VanOort has made a $500,000 investment into NeoGenomics by...

2009-03-05 06:00:00

FT. MYERS, Fla., March 5 /PRNewswire-FirstCall/ -- NeoGenomics, Inc. (NASD OTC Bulletin Board: NGNM), an operator of a network of cancer-focused testing laboratories, today announced its results for the fourth quarter and full-year ended December 31, 2008. Fourth Quarter 2008 Highlights: Revenue of $5.9 million, an increase of 56% year-over-year from Q4 07 17.2% sequential increase in revenues in Q4 08 vs. Q3 08 Avg. Rev/Requisition increased 13.7% in Q4 08 from Q4 07 Avg. Rev/Test...

2009-03-03 16:41:00

FT. MYERS, Fla., March 3 /PRNewswire-FirstCall/ -- NeoGenomics, Inc. (OTC Bulletin Board: NGNM) announced today that it plans to release its fourth quarter and full year 2008 financial results on Thursday March 5, 2009. The Company has scheduled a webcast and conference call to discuss their Q4 and full year 2008 results on March 5, 2009, at 11:00 AM EST. Interested investors should dial (877) 407-8033 (domestic) and (201) 689-8033 (international) at least five minutes prior to the call. A...

2009-02-11 13:47:00

FT. MYERS, Fla., Feb. 11 /PRNewswire-FirstCall/ -- NeoGenomics, Inc. (OTC Bulletin Board: NGNM), a leading provider of cancer genetics testing services, announced today that President and Chief Scientific Officer, Bob Gasparini, will present at the Roth Capital Partner's 21st Annual OC Growth Stock Conference in Dana Point, California. The date, time and location of the Company's presentation at the conference are as follows: Date: Monday, February 16, 2009 Time:...